Current and future recombinant viral vaccines for poultry.
The use of biotechnology to create recombinant viral vaccines holds many promises for the future. But, to be practical, new vaccines must have a selective advantage over traditional vaccines. A vaccine that is novel because it is a recombinant vaccine is not enough. Recombinant vaccines must be safer, or more efficacious, or less expensive to produce in order for them to gain a niche in the marketplace.
Jackwood
M W
MW
Department of Avian Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
D000818:Animals; D001709:Biotechnology / Q000379:methods / Q000639:trends; D002645:Chickens; D005586:Fowlpox / Q000276:immunology / Q000517:prevention & control; D005587:Fowlpox virus; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary; D011201:Poultry Diseases / Q000276:immunology* / Q000517:prevention & control; D014422:Turkeys; D014611:Vaccination / Q000379:methods / Q000639:trends / Q000662:veterinary; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
D014614:Vaccines, Synthetic; D014765:Viral Vaccines